C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/04 (2006.01) A61K 31/175 (2006.01) A61K 39/39 (2006.01) A61P 31/12 (2006.01) C07C 335/40 (2006.01) C07D 213/53 (2006.01) C07D 233/64 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 405/12 (2006.01) C07D 413/10 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2511646
Novel immune potentiators, novel vaccine adjuvants, novel compounds and pharmaceutical compositions, as well as novel methods for treating viral infections, including HCV, by administering the compounds and compositions, and novel methods for modulating the immune response by administering the compounds and/or compositions.
L'invention concerne de nouveaux immunostimulants, de nouveaux adjuvants de vaccins, de nouveaux composés et de nouvelles compositions pharmaceutiques, ainsi que de nouvelles méthodes de traitement d'infections virales, y compris le VHC, par administration desdits composés et compositions, et de nouvelles méthodes de modulation de la réponse immune par administration de ces composés et/ou compositions.
Barsanti Paul
Brammeier Nathan
Diebes Anthony
Lagniton Liana
Ng Simon
Borden Ladner Gervais Llp
Chiron Corporation
Novartis Vaccines And Diagnostics Inc.
LandOfFree
Thiosemicarbazones as anti-virals and immunopotentiators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiosemicarbazones as anti-virals and immunopotentiators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiosemicarbazones as anti-virals and immunopotentiators will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2046176